Abstract
Ewing sarcoma is an exceedingly rare form of cancer that affects the cervix. It falls within the spectrum of neoplastic diseases known as Ewing’s family of tumours, typically observed in osseous tissues. A woman in her 40s, experiencing symptoms of leucorrhoea and transvaginal bleeding that commenced 3 months before her consultation, was referred to our gynaecological oncology clinic with a preliminary diagnosis of ovarian teratoma. A colposcopy procedure was conducted unveiling a complete loss of cervical anatomy with friable and malodorous tissue. Pelvic ultrasound identified a lesion of uncertain origin in the cervix, suggestive of malignancy. Histopathological assessment of cervical biopsy specimens confirmed the presence of a small, round, blue cell neoplasm consistent with Ewing sarcoma. She underwent chemotherapy and pelvic radiotherapy, achieving complete remission 9 months after diagnosis, without experiencing any systemic adverse effects or sequelae.
Reference14 articles.
1. Incidence of Ewing’s sarcoma in different age groups, their associated features, and its correlation with primary care interval;Khan;Cureus,2021
2. Uncommon Sarcomas of the uterine Cervix: A review of selected entities;Fadare;Diagn Pathol,2006
3. Durer S , Shaikh H . Ewing sarcoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. Available: https://www.ncbi.nlm.nih.gov/books/NBK559183/
4. Primary Ewing’s sarcoma/primitive Neuroectodermal tumour of the Cervix: a rare tumour;Gupta;Indian J Surg Oncol,2020
5. Therapeutic potential of Ewsr1-Fli1 inactivation by CRISPR/Cas9 in Ewing sarcoma;Cervera;Cancers (Basel),2021